StockData
Danaher Corp logo

Danaher Corp

DHRNYSEIndustrial Instruments For Measurement, Display, and ControlFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 26, 2026Last filing: 10-Q on Jul 21, 2026Score 12/3027% above fair value
$232.23−4.75 (-2.00%)

Close on Oct 30, 2026Market cap $163.25BP/E 41.2Yield –

Danaher Diagnostics by Quarter

Diagnostics — Nonrecurring Equipment Revenue (Nonrecurring: Outright Diagnostic Instrument Sales) ($M)

QuarterlyAnnual

Danaher Diagnostics: $349M in Q3 2026, up 38.5% from a year earlier.

Latest, Q3 2026
349
Period ended Sep 30, 2026
Change on a year earlier
+38.5%
252 in Q3 2025
History
15 quarters
Since Q1 2023
Sources
10
Documents cited below

Where the Q3 2026 figure comes from

Source: Danaher SEC 10-Q (2026Q3, filed 2026-10-21) ↗

2-dimensional revenue breakdown in Revenue Disclosures (Note 3 / Note 6, continuing operations basis following the Veralto spin-off); Q4 is calculated as Full Year (10-K) minus 9-month (10-Q Q3).

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedDiagnostics — Nonrecurring Equipment Revenue (Nonrecurring: Outright Diagnostic Instrument Sales) ($M)Year on yearSource
Q3 2026Sep 30, 2026349+38.5%Danaher SEC 10-Q (2026Q3, filed 2026-10-21) ↗
Q2 2026Jun 30, 2026256+3.6%Danaher SEC 10-Q (2026Q2, filed 2026-07-21) ↗
Q1 2026Mar 31, 2026231+2.2%Danaher SEC 10-Q (2026Q1, filed 2026-04-21) ↗
Q4 2025Dec 31, 2025357+4.4%Danaher SEC 10-K (FY2025, filed 2026-02-24) ↗
Q3 2025Sep 30, 2025252+6.8%Danaher SEC 10-Q (2026Q3, filed 2026-10-21) ↗
Q2 2025Jun 30, 2025247-3.9%Danaher SEC 10-Q (2026Q2, filed 2026-07-21) ↗
Q1 2025Mar 31, 2025226-3.0%Danaher SEC 10-Q (2026Q1, filed 2026-04-21) ↗
Q4 2024Dec 31, 2024342-1.4%Danaher SEC 10-K (FY2025, filed 2026-02-24) ↗
Q3 2024Sep 30, 2024236-11.9%Danaher SEC 10-Q (2025Q3, filed 2025-10-21) ↗
Q2 2024Jun 30, 2024257-5.9%Danaher SEC 10-Q (2025Q2, filed 2025-07-22) ↗
Q1 2024Mar 31, 2024233-11.7%Danaher SEC 10-Q (2025Q1, filed 2025-04-22) ↗
Q4 2023Dec 31, 2023347–Danaher SEC 10-K (FY2025, filed 2026-02-24) ↗
Q3 2023Sep 30, 2023268–Danaher SEC 10-Q (2024Q3, filed 2024-10-22) ↗
Q2 2023Jun 30, 2023273–Danaher SEC 10-Q (2024Q2, filed 2024-07-23) ↗
Q1 2023Mar 31, 2023264–Danaher SEC 10-Q (2024Q1, filed 2024-04-23) ↗

Cite this data

StockData. (2026). Danaher Diagnostics ($M), quarterly Q1 2023–Q3 2026 [Data set]. Compiled from Danaher SEC filings and investor materials. https://stockdatahq.com/stocks/dhr/kpis/disagg-diag-type-nonrecurring

See every metric in the Danaher KPI table. Data updated Nov 2, 2026.